pyrroles has been researched along with Cancer of Gallbladder in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lorenz, J; Mössner, J; Wiedmann, M; Wolf, S | 1 |
Ahmadzadeh, A; Babaei, M; Elahi, F; Hassanpour, K; Yadollahzadeh, M | 1 |
DiGiovanni, J; Franco, E; Fujiwara, K; Hanai, M; Kawamoto, T; Kiguchi, K; Kurakata, S; Ruffino, L; Rumi, M | 1 |
3 other study(ies) available for pyrroles and Cancer of Gallbladder
Article | Year |
---|---|
Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance.
Topics: Antineoplastic Agents; Biliary Tract Neoplasms; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Gallbladder Neoplasms; Gemcitabine; Humans; Proto-Oncogene Proteins c-akt; Pteridines; Pyrimidines; Pyrroles; Receptor, IGF Type 1 | 2010 |
Neuroendocrine tumor of the gallbladder.
Topics: Antineoplastic Agents; Carcinoma, Neuroendocrine; Catheter Ablation; Cisplatin; Deoxycytidine; Docetaxel; Drug Therapy, Combination; Female; Gallbladder; Gallbladder Neoplasms; Gemcitabine; Humans; Indoles; Middle Aged; Pyrroles; Sunitinib; Taxoids; Ultrasonography | 2013 |
Therapeutic effect of CS-706, a specific cyclooxygenase-2 inhibitor, on gallbladder carcinoma in BK5.ErbB-2 mice.
Topics: Administration, Oral; Animals; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; ErbB Receptors; Fluorescent Antibody Technique; Gallbladder Neoplasms; Mice; Mice, Transgenic; Pyrroles; Receptor, ErbB-2; Sulfonamides | 2007 |